baber/WOPTO huggingface dataset:
Patent CA-2662629-A1 (CA)
Inventor: PEMBERTON CHRISTOPHER JOSEPH
IPC: C07K14/47
Filed: 2007-09-07
Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distiniguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.
Patent CA-2663909-A1 (CA)
Inventor: GROTE CHRISTOPHER W
IPC: C07D217/20
Filed: 2007-09-06
Abstract: The present invention is directed to processes for the synthesis of morphinan-6-ones and salts, intermediates, and analogs thereof.
Patent CA-2665404-A1 (CA)
Title: High-level hypermedia synthesis for adaptive web
Inventor: NADJARBASHI-NOGHANI MEHRAN
IPC: G06F9/45
Filed: 2009-05-05
Abstract: A process for dynamically generating browser-ready code from a high-level code description of a web page written in a first predefined language having one or more adaptive features and from one or more constraints associated with a request for such browser-ready code.
Patent CA-2666424-A1 (CA)
Inventor: ZEMLA DAVID
IPC: B60C11/00
Filed: 2007-07-24
Abstract: The invention provides a method for balancing tire performance with both increased and decreased numbers of lugs on the ribs while also having desirable tire noise performance. This method allows the tire designer to take advantage of the benefits of both high and low pitch count patterns while minimizing undesirable tire noise. The method involves the design of the fundamental pitch of the tire tread pattern and the design of the tread pattern for the tire. The invention also provides tires incorporating the fundamental pitch and tread patterns.
Patent CA-2667493-A1 (CA)
Inventor: FRANKE OLIVER
IPC: C07C29/60
Filed: 2007-06-16
Abstract: The invention provides a process for preparing 1,2-propanediol, by reacting glycerol which has a purity of at least 95% by weight with hydrogen at a hydrogen pressure of from 20 to 100 bar and a temperature of from 180 to 240°C in the presence of a catalyst which comprises from 10 to 50% by weight of copper oxide and from 50 to 90% by weight of zinc oxide in an autoclave.
Patent CA-2669740-A1 (CA)
Inventor: GRANGER JACQUES
IPC: B65D47/02
Filed: 2007-12-06
Abstract: Dispositif d'irremplissabilité (3, 3'), destiné à être fixé de manière irréversible au goulot (40) d'un récipient contenant un liquide et à être fermé par une capsule de bouchage (2, 2'), ledit dispositif présentant un axe (10) coïncidant avec l'axe dudit goulot lorsqu'il est fixé sur celui-ci, caractérisé en ce qu'il présente un conduit axial (39, 39') de distribution dudit liquide traversé par une paroi transversale (6, 6'), fixée de façon irréversible audit dispositif d'irremplissabilité (3, 3') et munie d'une pluralité de canaux traversants (63), chacun desdits canaux traversants (63) reliant un orifice extérieur (60) orienté vers l'extérieur du récipient à un orifice intérieur (61) orienté vers l'intérieur du récipient, la plus petite dimension dudit orifice extérieur (60) étant inférieure à une dimension critique déterminée en fonction de la tension de surface critique du matériau constitutif de ladite paroi transversale, typiquement voisine de 0,7 mm, et dans lequel la plus petite dimension dudit orifice intérieur (61) est supérieure à ladite dimension critique.
Patent CA-2669880-A1 (CA)
Inventor: GRANT THOMAS E JR
IPC: A61B5/117
Filed: 2006-05-11
Abstract: A preferably non-electrical nerve communication enhancement tool that sends specific, pre-timed, controlled vibrational and/or acoustical stimulation frequencies to the body to enhance nerve communication for the purpose of improving muscle memory, coordinated functional musculoskeletal performance improvement and enhanced blood flow, increased range of motion, flexibility, strength and dexterity, neuromuscular re-education, muscle tone recovery, pain modulation, improved eye-hand coordination, gait improvement, stability gains, kinetic chain integration, neurological performance enhancement, sensory dysfunction reduction, and improvement in mental and cognitive function.
Patent CA-2670896-A1 (CA)
Title: Apparatus for dispensing and detecting solid pharmaceutical articles and related methods of operation
Inventor: RIVENBARK JAMES ROBERT JR
IPC: A61J7/02
Filed: 2009-06-30
Abstract: A method for dispensing and detecting solid pharmaceutical articles includes: forcing an article through a dispensing channel and past a sensor configured and positioned to detect the article passing through the dispensing channel, wherein the article includes one of the solid pharmaceutical articles; generating a detection signal using the sensor responsive to the article passing through the dispensing channel, wherein the detection signal indicates a time that the article takes to traverse the sensor; and determining whether the article is a complete article or an article fragment responsive to a comparison of the time indicated by the detection signal and an article fragment travel time representing an expected travel time for a complete article to traverse the sensor that is determined independent of physical attributes of the solid pharmaceutical articles.
Patent CA-2672735-A1 (CA)
Inventor: WALKER TORIN
IPC: H04W4/18
Filed: 2007-12-13
Abstract: In embodiments, the present invention provides a method and system for sourcing, encoding, management, hosting, financial mediation, transaction settlement, and delivery of mobile content with a mobile media platform, and delivering content to a mobile device..
Patent CA-2673230-A1 (CA)
Inventor: SATO SHIGERU
IPC: F03D11/04
Filed: 2007-12-18
Abstract: Provided is a wind power apparatus which can make effective use of the energy of a weak wind irrespectively of the wind direction thereby to generate an electric power efficiently, and which can meet upsizing and power increase easily with a simple structure. The wind power apparatus comprises a wind tunnel constituted of a cylindrical member erected vertically from a foundation, a plurality of wind-collecting plates extending in the direction of the normal to the circumferential wall of the cylindrical member, a plurality of vertical guide plates disposed between the wind-collecting plates, a plurality of wind inlets for introducing the wind collected by the wind-collecting plates, into the wind tunnel, back-flow preventing means for allowing only the flow of the wind from the outside of the cylindrical member to the inside of the cylindrical member, a turbine to be driven by the wind blown from one end portion of the wind tunnel, and a power generator to be driven by the turbine.
Patent CA-2674443-A1 (CA)
Inventor: COLESCOTT MICHAEL G
IPC: H01R13/62
Filed: 2008-01-10
Abstract: A connector comprises an adapter housing coupled to a connector housing. An adapter insert has a first cavity formed therein. The first cavity is shaped to at least partially restrain motion in a first lateral axis of a flat cable placed therein. An apparatus for connecting a flat cable to an electrical connector comprises an adapter housing. An adapter insert has a first cavity shaped to at least partially restrain motion in a first lateral axis of a flat cable placed therein. An elastomer spring element is disposed in a second cavity in the adapter insert. The elastomer spring element imparts a squeeze on the flat cable at least partially restraining motion of the flat cable in a second lateral axis substantially orthogonal to the first lateral axis.
Patent CA-2677743-A1 (CA)
Inventor: MAXON BARTLEY D
IPC: A61K9/107
Filed: 2008-02-08
Abstract: Cette invention se rapporte à des compositions en émulsion qui peuvent réchauffer un contact avec l'humidité ambiante et qui peuvent être utilisées comme lubrifiant sur la peau d'une personne. Elles peuvent être formulées sous la forme d'une lotion.
Patent CA-2678417-A1 (CA)
Title: Decontamination unit and process
Inventor: CENTANNI MICHAEL A
IPC: A61L2/20
Filed: 2008-02-20
Abstract: The disclosed invention relates to a decontamination unit which is energy efficient and may be used to decontaminate a large enclosure such as a multi-room building. The invention also relates to a decontamination process. The decontamination unit may be ruggedized for use in hostile environments such as those that may be anticipated for military applications.
Patent CA-2679949-A1 (CA)
Inventor: EATON ROBERT F
IPC: C08K5/00
Filed: 2008-03-11
Abstract: Thermally activated, free-radical initiator-containing polymer compositions comprise a (i) free radical initiator, (ii) free radical crosslinkable polymer, (iii) scorch inhibiting amount and/or a cure-boosting amount of at least one of isocyanate, diisocyanate, e.g., MDI, or hydroxyalkyl (meth)acrylate compound, e.g., hydroxyethyl (meth)acrylate, and, optionally, (iv) other scorch retardants and/or cure boosters, e.g., a TEMPO compound, a hindered phenol, alpha-methyl styrene dimer, etc.. The free radical initiator can be any thermally activated compound that is relatively unstable and easily breaks into at least two radicals, e.g., a peroxide or azo initiator. The crosslinkable polymer is a thermoplastic and/or elastomeric polymer that can be crosslinked (cured) through the action of a crosslinking agent, e.g., LDPE. The isocyanate, diisocyanate and (meth)acrylate scorch inhibitors and/or cure boosters can be used alone, or in combination with one another, or, optionally, in combination with a TEMPO compound, e.g., 4-hydroxy-TEMPO.
Patent CA-2680785-A1 (CA)
Title: Spray wood coating system having improved holdout
Inventor: WINKLE BRADLEY J
IPC: E04C2/10
Filed: 2008-03-17
Abstract: A wood substrate is coated by spray- applying onto the substrate a 100% solids transparent coating composition containing sufficient silica-containing semithixotropic particulate having an average particle size of about 1 to about 20 micrometers to provide improved coating holdout, and curing the thus-applied coating. The coating may be applied at lower wet coating weights (thinner wet coating thicknesses) than a coating that does not employ silica-containing semithixotropic particulate. On variable grain density wood substrates such as cherry, the coating exhibits less localized soak in (better holdout) and provides a cured finish with a more uniform appearance over high and low grain density regions.
Patent CA-2681394-A1 (CA)
Inventor: MYRSTAD TROND
IPC: C07C1/00
Filed: 2008-03-20
Abstract: A process for the preparation of a biogasoline component comprising: (I) obtaining at least one biooil and, if necessary, liquefying the biooil component; (II) adding the bio-oil in liquid form to a FCC unit along with at least one mineral oil; (III) cracking the components added to the FCC unit to form at least a bio-LPG fraction and a bio-naphtha fraction; (IV) alkylating or catalytically polymerising at least part of the bio-LPG fraction; and (V) combining at least a part of the product of step (IV) with at least a part of the bio-naphtha fraction to form a bio-gasoline component.
Patent CA-2681537-A1 (CA)
Title: Novel benzamide derivatives as modulators of the follicle stimulating hormone
Inventor: RICCABONI MAURO
IPC: C07C233/15
Filed: 2008-03-19
Abstract: The present invention provides new compounds of formula I, wherein Q, R1, R2, R4, R5, R6, Xi, R7, R8, M and G1 n are defined as in formula I; invention compounds are modulators of follicle-stimulating hormone - ("FSH") which are useful for male and female contraception as well as other disorders modulated by FSH receptor.
Patent CA-2682223-A1 (CA)
Inventor: HOUSER KEVIN L
IPC: A61B17/20
Filed: 2008-03-18
Abstract: An ultrasonic surgical blade that includes a blade body that has a treatment region. At least one indentation can be formed in the treatment region of the blade body wherein each indentation forms a tissue cutting edge with an outer surface of the blade body. The indentation may comprise one or more holes, lumens, grooves or dimples or a combination of such structures. In various embodiments, one or more aspiration lumens are provided in the surgical blade which may ultimately communicate with an aspiration lumen or passage in an ultrasonic surgical instrument.
Patent CA-2687586-A1 (CA)
Inventor: DA CRUZ LUIS A G
IPC: A61K39/395
Filed: 2008-05-23
Abstract: Expression of TROP-2, an approximately 35 kDa transmembrane protein and a substrate of protein kinase C, has been linked to several cancers. TROP-2 is also known as GA733-1, epithelial glycoprotein 1 (EGP-I) and tumor-associated calcium signal transducer-2. A monoclonal antibody against TROP-2 from the hybridoma AR47A6.4.2, deposited with the International Depository Authority of Canada (IDAC) as accession number 141205-05, was previously shown to be a cancerous disease modifying antibody (CDMAB), preventing tumour growth and reducing tumour burden in several cancer models including prostate, pancreatic and breast cancer by cytotoxicity. The variable regions of this monoclonal antibody were also isolated, sequenced and complementarity determining regions (CDRs) determined. Now, a chimeric antibody and humanized antibodies are generated that have similar TROP-2 binding activity as the parent 141205-05 monoclonal antibody. The monoclonal, chimeric and humanized antibodies can be conjugated to toxins, enzymes, radioactive compounds, cytokines, interferons, target or reporter moieties and hematogenous cells to treat cancer. These antibodies are also used in binding assays to determine TROP-2 expression on cells.
Patent CA-2689126-A1 (CA)
Title: System and method for analyzing unauthorized intrusion into a computer network
Inventor: CAPALIK ALEN
IPC: G06F21/56
Filed: 2008-04-15
Abstract: The method analyzes unauthorized intrusion into a computer network. Access is allowed through one or more open ports to one or more virtualized decoy operating systems running on a hypervisor operating system hosted on a decoy network device. This may be done by opening a port on one of the virtualized decoy operating systems. A network attack on the virtualized operating system is then intercepted by an introspection module running on the hypervisor operating system. The attack-identifying information is communicated through a private network interface channe and stored on a database server as forensic data. A signature-generation engine uses this forensic data to generate a signature of the attack. An intrusion prevention system then uses the attack signature to identify and prevent subsequent attacks. A web-based visualization interface facilitates configuration of the system and analysis of (and response to) forensic data generated by the introspection module and the signature generation engine, as well as that stored in the processing module's relational databases.
Patent CA-2689986-A1 (CA)
Inventor: HART CHARLES E
IPC: A61K38/18
Filed: 2008-06-03
Abstract: The present invention relates to compositions and methods useful for treating structures of the vertebral column, including vertebral bodies. In one embodiment, a method for promoting bone formation in a vertebral body comprising providing a composition comprising a PDGF  solution and a biocompatible matrix and applying the composition to at least one vertebral body. Promoting bone formation in a vertebral body, according to some embodiments, can increase bone volume, mass, and/or density leading to an increase in mechanical strength of the vertebral body treated with a composition of the present invention.
Patent CA-2690758-A1 (CA)
Inventor: SPANDORFER MICHAEL
IPC: A61M16/00
Filed: 2008-06-13
Abstract: An automated drug delivery and monitoring system for use on mechanically ventilated patients in the intensive care unit is presented. Medication in the form of respirable particles is transported through ventilator circuitry by a delivery unit. Multiple medications may be delivered into the gas flow of the ventilator, with each medication delivered in a defined dose for a frequency and interval as specified by an operator. The particles mixed into the gas flow of the ventilator are inhaled and ingested by the patent's lungs.
Patent CA-2691047-A1 (CA)
Inventor: DU PREEZ JAN GYSBERT HERMANUS
IPC: C07F15/00
Filed: 2008-06-18
Abstract: Provided are nitroplatinum(IV) complexes containing a bidentate dicarboxylate ligand (e.g., oxalate) which maybe useful treating various forms of proliferative diseases, such as cancer. In some instances the platinum(IV) complexes are relatively stable and may be suitable for oral administration. Also provided are methods of treatment, as well as kits and unit dosages.
Patent CA-2693123-A1 (CA)
Inventor: AMIROV THOMAS
IPC: A61B17/16
Filed: 2007-07-31
Abstract: A carbon shafted reaming device, wherein the reaming device comprises a rod element (10), an interface element (20, 30) and a connecting agent (40), wherein the rod element (10) comprises a first connecting portion (11) having a carbon fibre reinforced structure, wherein the interface element (20, 30) comprises a second connecting portion (21, 31), wherein the first connecting portion (11) and the second connecting portion (21, 31) are concentrically arranged to each other, and wherein the connecting agent (40) is interposed between the first connecting portion (11) and the second connecting portion (21, 31). Either of the rod element and the interface element may be coupled to a reaming tool or a drive.
Patent CA-2693255-A1 (CA)
Inventor: CHEN YVONNE
IPC: C07K16/28
Filed: 2008-07-15
Abstract: The present invention is directed to humanized and conjugated antibodies against CD79b useful for the treatment of hematopoietic tumor in mammals and to methods of using those antibodies for the same.
Patent CA-2695492-A1 (CA)
Title: Process for demineralization of bone matrix with preservation of natural growth factors
Inventor: SHELBY NANCY JANE
IPC: A61F2/30
Filed: 2008-06-02
Abstract: A demineralized bone matrix is produced by a process in which a bone body is placed in a first processing solution comprising an acid to demineralize the bone body. The bone body is periodically removed from the first solution at specific time intervals to perform at least one test, such as a compression test, on a mechanical property of the bone body. When the test yields a desired result, the bone body is exposed to a second processing solution that is less acidic than the first, thus minimizing the exposure of the bone body to the harsh acidic conditions of the demineralization phase of the process.
Patent CA-2697150-A1 (CA)
Inventor: ZALIT ILAN
IPC: A61K9/20
Filed: 2008-08-18
Abstract: Provided are methods and compositions for controlling the bioavailability of poorly soluble drugs, including, for example, efravirenz.
Patent CA-2698711-A1 (CA)
Title: Explosion-induced g-force absorption apparatus
Inventor: STEVENS ROBERT
IPC: B60N2/42
Filed: 2008-06-30
Abstract: The invention relates to apparatus which absorbs G-force resulting from an explosion event near a vehicle in order to protect the occupant from potentially dangerous levels of G-force. The apparatus has first (12) and second mounting (14) attached to the occupant seat. An absorbtion mechanism (20) in the form of a mitigating strip (22) is provided between the mounting members and an anvil (28) is provided on such that when the vehicle, and hence the first mounting member, is subjected to the explosion induced G-force, the mitigating strip is bent and pulled over the anvil. This absorbs a portion of the G-force which would otherwise he imparted on the occupant hence minimising the risk of injury to the occupant. A method of protecting a vehicle occupant from explosion induced G-force is also provided.
Patent CA-2699310-A1 (CA)
Inventor: VENDROW VLAD
IPC: H04M7/00
Filed: 2008-09-25
Abstract: Examples of inbound call identification and management are described including a call management system that includes one or more repositories that can include data representing call action policies and data representing attributes associated with the caller devices and the callee devices.    Further, the call management system can include one or more computing devices that include a call identifier ("IDer") configured to characterize the attributes of the caller devices to form characterized attributes, a call management system controller configured to match the characterized attributes against routing criteria specified in the data representing the call action policies, and a call management system router configured to route calls from the caller devices to the callee devices responsive to a match between the characterized attributes and the routing criteria.
Patent CA-2699542-A1 (CA)
Inventor: PATTERSON DARYLL D
IPC: G05D16/10
Filed: 2008-08-28
Abstract: Adjustable in-line fluid regulators are de-scribed. One described example fluid regulator includes a body having a fluid inlet and a fluid outlet. The example regulator also includes a first fluid regulator having a valve to control the flow of fluid from the inlet to the outlet, a pis-ton coupled to the valve via a stem, wherein the piston is to receive a pressure associated with the outlet. The first fluid valve also includes a spring plate movable along a longitu-dinal axis of the stem, a spring disposed between the piston and the spring plate, and an adjuster engaged with the body to move the spring plate to change a compression of the spring and a regulated outlet pressure of the fluid regulator.
Patent CA-2701354-A1 (CA)
Inventor: PAYNE THOMAS
IPC: A61K35/12
Filed: 2008-10-03
Abstract: The present invention relates to muscle-derived progenitor cells (MDCs) and compositions of MDCs and their use in the augmentation of body tissues, particularly skeletal muscle. In particular, the present invention relates to muscle-derived progenitor cells that show long-term survival following introduction into skeletal muscle, methods of isolating MDCs and methods of using MDC-containing compositions for the augmentation of human or animal skeletal muscle.
Patent CA-2702315-A1 (CA)
Inventor: SMITH PAUL DAVID
IPC: C07D239/70
Filed: 2008-10-13
Abstract: This invention relates to a combination product, as defined herein, comprising a MEK inhibitor and a mTOR-selective inhibitor, and to methods for the production of an anti-cancer effect in a patient, which is accordingly useful in the treatment of cancer in a patient. More specifically the present invention relates to; a combination product, as defined herein, comprising a MEK inhibitor and a mTOR-selective inhibitor; a combination product, as defined herein, comprising a kit of parts comprising a MEK inhibitor and a mTOR-selective inhibitor; use of the combination product, as defited herein, in the treatment of cancer; a method of treating cancer comprising administering the combination product, as defined herein, to a patient. The combination product, as defined herein, and methods of the invention are also useful in the treatment ol other diseases associated with the activity of MEK, and/or mTOR.
Patent CA-2702376-A1 (CA)
Inventor: LAMBRECHTS STIJN
IPC: A61K49/00
Filed: 2008-10-20
Abstract: The invention relates generally to the field of tissue engineering. More particularly, the present invention relates to methods for identifying a population of cells suitable for the repair of connective tissue, including cartilage. The invention further provides methods and compositions related to the generation of a population of cells suitable for the repair of cartilage, in particular in the repair of cartilage degeneration associated with osteoarthritis.  Methods of using said cells thus identified or thus generated, in methods to extend the period of cell manipulation, i.e. to increase the yield of cells suitable in the aforementioned methods, are also provided by the present invention.